Kaiser discussed Patel’s relationships with Tesaro and Sigilon, further noting that Patel received a speaking fee in 2015 from Pharmaceutical Research and Manufacturers of America (PhRMA), an industry lobby, of $5,001 to $15,000.
Dr. Anupam Jena is a professor of health care policy at Harvard Medical School and a doctor at Massachusetts General Hospital. This year, he started a podcast through the Freakonomics Radio Network.
The National Academies report mentions three prizes Jena won, but it doesn’t say anything about his industry connections. According to the Open Payments database, from 2014 through 2020, those relationships involved more than $153,000 of general payments, more than $37,000 of research payments, and almost $75,000 of associated research funding. (In Open Payments, associated research funding includes payments made to an institution such as a hospital to support a doctor’s research.)
In all, the payments listed for Jena in the federal database number 177. The companies that made the payments include Celgene, Eli Lilly, Novartis, E.R. Squibb & Sons, Sanofi, Pfizer, Janssen, and Amgen.
According to Open Payments, Jena received consulting fees from Amgen on January 16, 2020, from Eisai on January 16, 2020, and from Otsuka Pharmaceutical Development & Commercialization on March 16, 2020.
Those three companies produce drugs of the type the committee was studying.
Nor does the National Academies’ report say anything about Jena’s work for two consulting firms, Precision Health Economics and Analysis Group.
Both appeared on a May 2020 disclosure form accompanying an article Jena co-authored for BMJ. The form said they paid him consulting fees. It didn’t say who, if anyone, paid the consulting firms for his services.
Precision Health Economics, which is now PRECISIONheor, and Analysis Group did not respond to lists of questions for this story.
"had" - Google News
October 29, 2021 at 10:59AM
https://ift.tt/3pLBfuS
At Least Half of Panel Advising Congress on Drug Policy had Undisclosed Ties to Drug Makers - Project On Government Oversight (POGO)
"had" - Google News
https://ift.tt/2KUBsq7
https://ift.tt/3c5pd6c
Bagikan Berita Ini
0 Response to "At Least Half of Panel Advising Congress on Drug Policy had Undisclosed Ties to Drug Makers - Project On Government Oversight (POGO)"
Post a Comment